Fresenius Group Overview

Outlook

Group Outlook 2019

In 2019, we expect to increase Group sales1 by 3% to 6% in constant currency. We project Group net income2,3 to increase by ~ 0% in constant currency.

  Targets 2019 Fiscal year 20184
Fresenius Group
Sales growth (in constant currency) 3% – 6%5 € 33,009 million

Net income2 growth
(in constant currency)

 ~0%6 € 1,872 million
Fresenius Medical Care

Sales growth (in constant currency)

 3% – 7%6 € 16,026 million
Net income7 growth (in constant currency) -2% – +2%6 € 1,341 million
Fresenius Kabi
Sales growth (organic) 3% – 6%6 € 6,544 million
EBIT growth (in constant currency) 3% – 6%6 € 1,139 million
Fresenius Helios
Sales growth (organic) 2% – 5%6 € 8,993 million
EBIT growth -5% – -2%6 € 1,052 million
Fresenius Vamed
Sales growth (organic) ~10%6 € 1,688 million
EBIT growth 15% – 20%6 € 110 million

 

  • 1 Base 2018: €33,009 million; 2018 adjusted for divestitures of Care Coordination activities at FMC (H1 / 18); 2019 adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 2 Net income attributable to shareholders of Fresenius SE & Co. KGaA
  • 3 Base 2018: € 1,872 million; 2018 before special items and adjusted for divestitures of Care Coordination activities at FMC (H1 /18); 2019 before special items (before transaction-related expenses, expenses associated with the cost optimization program at FMC, revaluations of biosimilars contingent liabilities), adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 4 Before special items and after adjustments
  • 5 Adjusted for effects of IFRS 16, excluding effects from pending acquisition of NxStage by FMC
  • 6 Before special items (before transaction-related expenses, expenses associated with the cost optimization program at FMC, revaluations of biosimilars contingent liabilities), adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 7 Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA
  •  
  • As of December 31, 2018

 

Contact us

Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com


Contact
Visit us

Fresenius SE & Co. KGaA

We use cookies to create cross-page statistical evaluations that we use to tailor our web pages to meet your needs. By clicking on "Yes", you agree to the use of these cookies. You will find more detailed information about these cookies and the associated data processing as well as the possibility of revocation in our data protection policy. To select individual types of cookies, please use the cookie settings.

Learn more
Yes No